Bronchoalveolar lavage cell populations in bleomycin lung toxicity.

Por White, D A, Kris, M G, Stover, D E
Publicado em 1987

Chemotherapy remains an essential element of personalized care for persons with lung cancers

Por Hellmann, M. D., Li, B. T., Chaft, J. E., Kris, M. G.
Publicado no Ann Oncol (2016)

Antiemetics and cytotoxic drugs.

Por Kris, M G, Gralla, R J, Tyson, L B, Clark, R A
Publicado em 1983

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Por Yu, H. A., Arcila, M. E., Hellmann, M. D., Kris, M. G., Ladanyi, M., Riely, G. J.
Publicado em 2014

Differences in survival of patients with recurrent versus de novo metastatic KRAS and EGFR mutant lung cancers

Por Yu, H. A., Sima, C. S., Hellmann, M. D., Naidoo, J., Busby, N., Rodriguez, K., Riely, G. J., Kris, M. G.
Publicado no Cancer (2015)

A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers(†)

Por Li, B. T., Drilon, A., Johnson, M. L., Hsu, M., Sima, C. S., McGinn, C., Sugita, H., Kris, M. G., Azzoli, C. G.
Publicado no Ann Oncol (2016)

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumo...

Por Kris, M. G., Camidge, D. R., Giaccone, G., Hida, T., Li, B. T., O'Connell, J., Taylor, I., Zhang, H., Arcila, M. E., Goldberg, Z., Jänne, P. A.
Publicado no Ann Oncol (2015)

Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers(†)

Por Yu, H. A., Sima, C., Feldman, D., Liu, L. L., Vaitheesvaran, B., Cross, J., Rudin, C. M., Kris, M. G., Pao, W., Michor, F., Riely, G. J.
Publicado no Ann Oncol (2017)

Clinical Characteristics and Course of 63 patients with BRAF Mutant Lung Cancers

Por Litvak, A.M., Paik, P.K., Woo, K. M., Sima, C. S., Hellmann, M. D., Arcila, M.E., Ladanyi, M., Rudin, C. M., Kris, M. G., Riely, G. J.
Publicado no J Thorac Oncol (2014)

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Por Drilon, A., Bergagnini, I., Delasos, L., Sabari, J., Woo, K. M., Plodkowski, A., Wang, L., Hellmann, M. D., Joubert, P., Sima, C. S., Smith, R., Somwar, R., Rekhtman, N., Ladanyi, M., Riely, G. J., Kris, M. G.
Publicado no Ann Oncol (2016)